- Investing Ideas
- /
- U.S. High Growth Potential Companies
U.S. High Growth Potential Companies
Results
1531
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
1,531 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ODD | US$45.38 | 5.1% | -2.2% | US$2.7b | US$54.78 | PE25.5x | E20.4% | n/a | Household | ||
EXFY | US$3.58 | 9.8% | 55.7% | US$354.2m | US$4.50 | PS2.4x | E94.2% | n/a | Software | ||
PHX | US$3.87 | -3.3% | 28.6% | US$151.4m | US$4.75 | PE30.7x | E92.1% | 4.1% | Energy | ||
TWFG | US$32.22 | 12.7% | n/a | US$1.7b | US$33.92 | PE74.9x | E40.1% | n/a | Insurance | ||
FREY | US$1.36 | -19.0% | -17.6% | US$238.6m | US$4.00 | PB0.4x | E111.9% | n/a | Capital Goods | ||
EOSE | US$3.99 | -6.5% | 294.6% | US$952.3m | US$5.14 | PS58x | E90.7% | n/a | Capital Goods | ||
PAHC | US$24.52 | 10.8% | 79.2% | US$921.1m | US$21.00 | PE51.4x | E66.1% | 2.0% | Pharmaceuticals & Biotech | ||
BHF | US$58.08 | -2.3% | 27.3% | US$3.5b | US$63.38 | PE11.9x | E30.9% | n/a | Insurance | ||
ITRM | US$1.33 | -8.9% | 7.3% | US$48.2m | US$7.50 | PE-1.9x | E69.4% | n/a | Pharmaceuticals & Biotech | ||
WK | US$86.16 | 2.6% | 0.6% | US$4.9b | US$119.94 | PS6.5x | E74.2% | n/a | Software | ||
NEOV | US$3.10 | -5.1% | 169.1% | US$123.3m | US$7.50 | PS41x | E100.7% | n/a | Capital Goods | ||
VCTR | US$62.34 | -2.4% | 60.1% | US$4.1b | US$74.11 | PE13.7x | E27.8% | 3.0% | Diversified Financials | ||
XELB | US$0.28 | -21.0% | -70.2% | US$7.1m | US$1.88 | PS0.7x | E105.9% | n/a | Retail | ||
AROC | US$26.03 | 0.9% | 41.8% | US$4.8b | US$31.00 | PE26.8x | E23.5% | 2.9% | Energy | ||
SUNS | US$12.08 | 1.9% | n/a | US$155.4m | US$14.31 | PE218.9x | E52.0% | 13.9% | Diversified Financials | ||
SOC | US$26.11 | -11.0% | 113.8% | US$2.5b | US$28.80 | PB13.9x | E117.2% | n/a | Energy | ||
JBTM | US$129.25 | 10.2% | 28.7% | US$6.9b | US$139.33 | PE80x | E52.1% | 0.3% | Capital Goods | ||
BA | US$170.06 | -5.5% | -15.2% | US$131.0b | US$195.81 | PS1.9x | E78.3% | 0% | Capital Goods | ||
TAL | US$12.44 | -6.9% | -7.3% | US$7.8b | US$14.98 | PE63.1x | E32.3% | 0% | Consumer Services | ||
SBFM | US$2.31 | -1.3% | -98.6% | US$4.6m | US$300.00 | PS0.1x | E208.2% | n/a | Pharmaceuticals & Biotech | ||
NBIX | US$114.48 | -3.9% | -14.0% | US$11.8b | US$166.13 | PE33.4x | E27.2% | n/a | Pharmaceuticals & Biotech | ||
FVRR | US$25.09 | -5.6% | 10.0% | US$965.6m | US$35.75 | PE49.4x | E24.7% | n/a | Commercial Services | ||
DKNG | US$41.59 | -6.1% | -7.3% | US$21.5b | US$57.59 | PS4.3x | E50.2% | n/a | Consumer Services | ||
MCHP | US$57.95 | -4.7% | -33.3% | US$31.7b | US$64.69 | PE100.9x | E42.3% | 3.1% | Semiconductors |